Rx IP Update provides timely reports and commentary on developments in Canadian intellectual property law that are of particular interest to the pharmaceutical industry, including summaries of new cases before the courts. If you have any comments on the content or presentation of Rx IP Update, or if you would like more information on a specific issue, please do not hesitate to contact Gunars Gaikis or Nancy Pei (editor). Please click here to subscribe to Rx IP Update
|
February 2012
Rx IP Update - January 2012 |
2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 |
